Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study


Creative Commons License

Aksu T., Guler T. E., ÇOLAK A., Baysal E., Durukan M., Sen T., ...Daha Fazla

BMC CARDIOVASCULAR DISORDERS, cilt.15, 2015 (SCI-Expanded) identifier identifier identifier

Özet

Background: Despite the advances in medical and interventional treatment modalities, some patients develop epicardial coronary artery reperfusion but not myocardial reperfusion after primary percutaneous coronary intervention (PCI), known as no-reflow. The goal of this study was to evaluate the safety and efficacy of intracoronary epinephrine in reversing refractory no-reflow during primary PCI.